Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation

被引：0

作者：

Takenaka, Katsuto ^{[1
]}

Fuji, Shigeo ^{[2
]}

Matsukawa, Toshihiro ^{[3
]}

Uchida, Naoyuki ^{[4
]}

Kobayashi, Takeshi ^{[5
]}

Tanaka, Masatsugu ^{[6
]}

Ara, Takahide ^{[7
,8
]}

Ikegame, Kazuhiro ^{[9
]}

Ozawa, Yukiyasu ^{[10
]}

Kanda, Yoshinobu ^{[11
]}

Sawa, Masashi ^{[12
]}

Maruyama, Yumiko ^{[13
]}

Fukuda, Takahiro ^{[14
]}

Nakamae, Hirohisa ^{[15
]}

Kimura, Takafumi ^{[16
]}

Ogata, Masao ^{[17
]}

Seo, Sachiko ^{[18
]}

Atsuta, Yoshiko ^{[19
,20
]}

Matsuo, Keitaro ^{[21
]}

Nakasone, Hideki ^{[22
]}

机构：

[1] Ehime Univ, Dept Hematol Clin Immunol & Infect Dis, Grad Sch Med, Toon, Japan

[2] Osaka Int Canc Ctr Inst, Osaka, Japan

[3] Hokkaido Univ, Dept Hematol, Fac Med, Sapporo, Hokkaido, Japan

[4] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan

[5] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan

[6] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa, Japan

[7] Hokkaido Univ, Dept Hematol, Fac Med, Sapporo, Hokkaido, Japan

[8] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan

[9] Hyogo Med Univ Hosp, Dept Hematol, Nishinomiya, Hyogo, Japan

[10] Nagoya Daiichi Hosp, Japanese Red Cross Aichi Med Ctr, Nagoya, Aichi, Japan

[11] Jichi Med Univ, Dept Med, Div Hematol, Shimotsuke, Tochigi, Japan

[12] Anjo Kosei Hosp, Dept Hematol & Oncol, Anjo, Aichi, Japan

[13] Univ Tsukuba Hosp, Dept Hematol, Tsukuba, Ibaraki, Japan

[14] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan

[15] Osaka Metropolitan Univ Hosp, Dept Hematol, Osaka, Japan

[16] Japanese Red Cross Kinki Block Blood Ctr, Preparat Dept, Osaka, Japan

[17] Oita Univ Hosp, Dept Hematol, Yufu City, Japan

[18] Dokkyo Med Univ, Dept Hematol & Oncol, Mibu, Tochigi, Japan

[19] Aichi Med Univ, Sch Med, Dept Registry Sci Transplant & Cellular Therapy, Nagakute, Aichi, Japan

[20] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagakute, Aichi, Japan

[21] Aichi Canc Ctr Res Inst, Div Mol Med, Nagoya, Aichi, Japan

[22] Jichi Med Univ, Div Hematol, Saitama Med Ctr, Saitama, Japan

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180906

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[1] Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
Hebert, Courtney
Watts, Nicole
Isaac, Shiney
Kukkamalla, Rivvi
Jamy, Omer
Saad, Ayman
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S276 - S277
[2] Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection
Katsuto Takenaka
Shigeo Fuji
Toshihiro Matsukawa
Naoyuki Uchida
Takeshi Kobayashi
Masatsugu Tanaka
Takahide Ara
Kazuhiro Ikegame
Yukiyasu Ozawa
Yoshinobu Kanda
Masashi Sawa
Yumiko Maruyama
Takahiro Fukuda
Hirohisa Nakamae
Takafumi Kimura
Masao Ogata
Sachiko Seo
Yoshiko Atsuta
Keitaro Matsuo
Hideki Nakasone
Annals of Hematology, 2024, 103 : 285 - 296
[3] Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection
Takenaka, Katsuto
Fuji, Shigeo
Matsukawa, Toshihiro
Uchida, Naoyuki
Kobayashi, Takeshi
Tanaka, Masatsugu
Ara, Takahide
Ikegame, Kazuhiro
Ozawa, Yukiyasu
Kanda, Yoshinobu
Sawa, Masashi
Maruyama, Yumiko
Fukuda, Takahiro
Nakamae, Hirohisa
Kimura, Takafumi
Ogata, Masao
Seo, Sachiko
Atsuta, Yoshiko
Matsuo, Keitaro
Nakasone, Hideki
ANNALS OF HEMATOLOGY, 2023, 103 (1) : 285 - 296
[4] Letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplantation
Azharuddin, Md
Sharma, Manju
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 149 - 149
[5] Risk factor analysis for cytomegalovirus reactivation under prophylaxis with letermovir after allogeneic hematopoietic stem cell transplantation
Mizuno, Kota
Sakurai, Masatoshi
Kato, Jun
Yamaguchi, Kentaro
Abe, Ryohei
Koda, Yuya
Kataoka, Keisuke
Mori, Takehiko
TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (06)
[6] Letermovir Prophylaxis for Cytomegalovirus Reactivation in β Thalassemia Major Children after Hematopoietic Cell Transplantation
Shi, Lingling
Liu, Rongrong
Zhang, Zhongming
Huang, Cuifeng
Liu, Lianjin
Yao, Yibin
Wei, Zhenbin
Wei, Shuyi
Gan, Zhaoping
Sun, Na
Liu, Beicai
Huang, Rui
Zhou, Xuemei
Chen, Yinghua
Liu, Qifa
Lai, Yongrong
BLOOD, 2023, 142
[7] Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data
Pang, Ian
Chen, Peggy
Trinh, Gertrude V.
Remberger, Mats
Novitzky-Basso, Igor
Gerbitz, Armin
Kim, Dennis D.
Kumar, Rajat
Lam, Wilson
Law, Arjun D.
Lipton, Jeffrey H.
Viswabandya, Auro
Pasic, Ivan
Mattsson, Jonas
Michelis, Fotios V.
EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 301 - 309
[8] Single center real-world data on Letermovir prophylaxis for cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation
Derigs, P.
Schubert, M. -L.
Schnitzler, P.
Mueller-Tidow, C.
Dreger, P.
Schmitt, M.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 173 - 173
[9] Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantation
Pfeiffer, Thomas
Lockowitz, Christine R.
Shenoy, Shalini
Mavers, Melissa
Hayashi, Robert
Bednarski, Jeffrey
Green, Abby
BONE MARROW TRANSPLANTATION, 2024, 59 (08) : 1193 - 1195
[10] CMV REACTIVATION AFTER STOPPING LETERMOVIR PRIMARY PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS
Chavaz, Lara
Royston, Lena
Masouridi-Levrat, Stavroula
Mamez, Anne-Claire
Giannotti, Federica
Morin, Sarah
Van Delden, Christian
Chalandon, Yves
Neofytos, Dionysios
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 93 - 93

← 1 2 3 4 5 →